ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Livmarli 9.5 mg/ml, Lösung zum Einnehmen - 30 ml
69201001 Mirum Pharmaceuticals AG
Livmarli 9.5 mg/ml, Lösung zum Einnehmen18.07.2024
  18.07.2024
Maralixibat Chloride (A05AX04) 
WHO-DDD17.07.2029
30 ml
04.99. 
B  
No 
IPCI
PR  
k.A.PR
  
7680692010018Synthetika
  
Composition
Lösung: maralixibatum 9.5 mg ut maralixibati chloridum, propylenglycolum, aqua purificata, dinatrii edetas corresp. natrium 0.124 mg, sucralosum, aromatica (Traubenaroma) cum propylenglycolum, ad solutionem pro 1 ml corresp. propylenglycolum 364.55 mg.
Packungsbestandteile
Solution (oral)
 
 
Active AgentDoseadditional_information
Maralixibatum9.5 mg/mlLösung
 
Inactive agents
Aqua Purificata
Aromatica (Traubenaroma) cum Propylenglycolum
Dinatrii Edetas
Propylenglycol
Sucralosum
Source
Data was imported : 07.08.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home